Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6atac small nuclear 14, pseudogene (RNU6ATAC14P) is classified as a non-coding RNA pseudogene in the human genome. It is related to the U6atac small nuclear RNA (snRNA), which in its functional (non-pseudogene) form participates in the formation of the minor spliceosome, a complex responsible for the splicing of a rare class of pre-mRNA introns. However, as a pseudogene, RNU6ATAC14P does not produce functional RNA and does not participate in biological pathways or disease processes. Unlike its functional counterparts, pseudogenes like RNU6ATAC14P are generally considered non-functional genomic elements formed by sequence duplication or retrotransposition events and serve no known direct cellular or therapeutic purpose. There are no known drugs, disease associations, biomarker uses, mechanisms of action, or safety concerns attributed to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6atac small nuclear 14, pseudogene (RNU6ATAC14P).